Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 1/2018

01-01-2018 | Therapy in Practice

Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options

Authors: Hilde Beele, Steven Smet, Nele Van Damme, Dimitri Beeckman

Published in: Drugs & Aging | Issue 1/2018

Login to get access

Abstract

Incontinence-associated dermatitis (IAD) is a common type of irritant contact dermatitis, seen in patients with urinary or faecal incontinence. Mechanical factors such as traumata and friction may aggravate the lesions. The fragile skin in elderly patients is more prone to developing IAD. The clinical picture of IAD consists of persistent redness on the one hand and skin loss on the other. Both categories may be associated with clinical signs of major colonisation or infection. It is important to distinguish IAD from pressure ulcers and other dermatoses in the genital region. Due to the lack of well-established clinical trials, recommendations about prevention and treatment are based on expert opinion and best practice. Gentle cleansing, use of hydrating topical agents and application of barrier products are the main elements in the prevention and treatment of IAD. It is important to translate these recommendations and general guidelines into ready-to-use protocols that can be implemented for each specific clinical manifestation of IAD.
Literature
1.
Junkin J, Selekof JL. Prevalence of incontinence and associated skin injury in the acute care inpatient. J Wound Ostomy Cont Nurs. 2007;34:260–9.CrossRef
2.
Campbell JL, Coyer FM, Osborne SR. Incontinence-associated dermatitis: a cross-sectional prevalence study in the Australian acute care hospital setting. Int Wound J. 2016;13:403–11.CrossRefPubMed
3.
Gray M, Beeckman D, Bliss DZ, Fader M, Logan S, Junkin J, et al. Incontinence-associated dermatitis: a comprehensive review and update. J Wound Ostomy Cont Nurs. 2012;39(1):61–74.CrossRef
4.
Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, et al. Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database Syst Rev. 2016;11:CD011627.PubMed
5.
Foureur N, Vanzo B, Meaume S. Prospective aetiological study of diaper dermatitis in the elderly. Br J Dermatol. 2006;155:941–6.CrossRefPubMed
6.
Fluhr JW, Elias PM. Stratum corneum pH: formation and function of the ‘acid mantle’. Exog Dermatol. 2002;1:163–75.CrossRef
7.
8.
Mugita Y, Minematsu T, Huang L, Nakagami G, Kishi C, Ichikawa Y, et al. Histopathology of incontinence-associated skin lesions: inner tissue damage due to invasion of proteolytic enzymes and bacteria in macerated rat skin. PLoS One. 2015;10:e0138117.CrossRefPubMedPubMedCentral
9.
Rayanfar P, Wallace JS, Pace NC. Diaper dermatitis: a review and update. Curr Opin Pediatr. 2012;24:472–9.
10.
Black JM, Bliss DZ, Logan S, Baharestani MM, Glodberg M, Rathcliff CR. MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus. J Wound Ostomy Continence Nurs. 2011;38:359–70.CrossRefPubMed
11.
Odio M, Thaman L. Diapering, diaper technology, and diaper area skin health. Pediatr Dermatol. 2014;31(Suppl 1):9–14.CrossRefPubMed
12.
Miyauchi Y, Shimaoka Y, Fujimura T, Koike Y, Yatabe M, Nishikawa M, et al. Developmental changes in neonatal and infant skin structures during the first 6 months: in vivo observation. Pediatr Dermatol. 2016;33(3):289–95.CrossRefPubMed
13.
Lagier L, Mazereeuw-Hautier J, Raffin D, Beneton N, Lorette G, Maruani A. Société française de dermatologie pédiatrique. Diaper dermatitis [in French]. Ann Dermatol Venereol. 2015;142(1):54–61.CrossRefPubMed
14.
Stamatas GN, Tierney NK. Diaper dermatitis: etiology, manifestations, prevention, and management. Pediatr Dermatol. 2014;31(1):1–7.CrossRefPubMed
15.
16.
Stalder JF, Tennstedt D, Deleuran M, Fabbrocini G, de Lucas R, Haftek M, et al. Fragility of epidermis and its consequence in dermatology. J Eur Acad Dermatol Venereol. 2014;28(Suppl 4):1–18.CrossRefPubMed
17.
18.
Kaya GL, Saurat JH. Dermatoporosis: a chronic cutaneous insufficiency/fragility syndrome. Clinicopathological features, mechanisms, prevention and potential treatments. Dermatology. 2007;215(4):284–94.CrossRefPubMed
19.
Mengeaud V, Dautezac-Vieu C, Josse G, Vellas B, Schmitt AM. Prevalence of dermatoporosis in elderly French hospital in-patients: a cross-sectional study. Br J Dermatol. 2012;166(2):442–3.CrossRefPubMed
20.
Visscher MD, Chatterjee R, Munson KA, Bare D, Hoath SB. Development of diaper rash in the newborn. Pediatr Dermatol. 2000;17:52–7.CrossRefPubMed
21.
Jacobs JJ, Lehé CL, Hasegawa H, Elliott GR, Das PK. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol. 2006;15(6):432–40.CrossRefPubMed
22.
Fluhr JW, Akengin A, Bornkessel A, Fuchs S, Praessler J, Norgauer J. Additive impairment of the barrier function by mechanical irritation, occlusion and sodium lauryl sulphate in vivo. Br J Dermatol. 2005;153(1):125–31.CrossRefPubMed
23.
Slotosch CM, Kampf G, Löffler H. Effects of disinfectants and detergents on skin irritation. Contact Dermat. 2007;57(4):235–41.CrossRef
24.
de Jongh CM, Khrenova L, Verberk MM, Calkoen F, van Dijk FJ, Voss H. Loss-of-function polymorphisms in the filaggrin gene are associated with an increased susceptibility to chronic irritant contact dermatitis: a case-control study. Br J Dermatol. 2008;159(3):621–7.CrossRefPubMed
25.
26.
Campbell JL, Coyer FM, Mudge AM, Robertson IM, Osborne SR. Candida albicans colonization, continence status and incontinence-associated dermatitis in the acute care setting: a pilot study. Int Wound J. 2017;14(3):488–95.CrossRefPubMed
27.
Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect. 2012;64(2):148–55.CrossRefPubMed
28.
Payne D. Not just another rash: management of incontinence-associated dermatitis. Br J Commun Nurs. 2016;21(9):434–40.CrossRef
29.
30.
Beeckman D, Van den Bussche K, Alves P, Arnold Long MC, Beele H, Ciprandi G, et al. Towards an international language for Incontinence-Associated Dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorisation Tool (GLOBIAD) in 30 countries. Br J. Dermatol. 2017. [Under review].
31.
Houwing RH, Koopman ES. Decubitus or incontinence-associated dermatitis? [in Dutch]. Ned Tijdschr Geneeskd. 2014;158:A7450.PubMed
32.
Defloor T, Schoonhoven L, Fletcher J, Furtado K, Heyman H, Lubbers M, et al. Trustees of the european pressure ulcer advisory panel. statement of the european pressure ulcer advisory panel—pressure ulcer classification: differentiation between pressure ulcers and moisture lesions. J Wound Ostomy Cont Nurs. 2005;32(5):302–6.CrossRef
33.
Pather P, Hines S. Best practice nursing care for ICU patients with incontinence-associated dermatitis and skin complications resulting from faecal incontinence and diarrhoea. Int J Evid Based Healthc. 2016;14(1):15–23.CrossRefPubMed
34.
Borchert K, Bliss DZ, Savik K. The incontinence-associated dermatitis and its severity instrument: development and validation. J Wound Ostomy Cont Nurs. 2010;37:527–35.CrossRef
35.
Kottner J, Lichterfeld A, Blume-Peytavi U. Incontinence-associated dermatitis: new insights into an old problem. Br J Nurs. 2016;25(5):256–62.CrossRef
36.
Lichterfeld A, Hauss A, Surber C, Peters T, Blume-Peytavi U, Kottner J. Evidence-based skin care: a systematic literature review and the development of a basic skin care algorithm. J Wound Ostomy Cont Nurs. 2015;42(5):501–24.CrossRef
37.
Corcoran E, Woodward S. Incontinence-associated dermatitis in the elderly: treatment options. Br J Nurs. 2013;22(8):1234–40.CrossRef
38.
Lynde CW. Moisturizers: what they are and how they work. Skin Therapy Lett. 2001;6(13):3–5.PubMed
39.
Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11):771–88.CrossRefPubMed
40.
Mostosi C, Simonart T. Effectiveness of barrier creams against irritant contact dermatitis. Dermatology. 2016;232(3):353–62.CrossRefPubMed
41.
Sparr E, Millecamps D, Isoir M, Burnier V, Larsson A, Cabane B. Controlling the hydration of the skin though the application of occluding barrier creams. J R Soc Interface. 2013;10(80):20120788.CrossRefPubMedPubMedCentral
42.
Del Rosso JQ. Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair. J Clin Aesthet Dermatol. 2014;7(2):40–8.PubMedPubMedCentral
43.
Corazza ML, Minghetti S, Bianchi A, Virgili A, Borghi A. Barrier creams: facts and controversies. Dermatitis. 2014;25(6):327–33.CrossRefPubMed
44.
45.
Beeckman D, Van Lancker A, Van Hecke A, Verhaeghe S. A systematic review and meta-analysis of incontinence-associated dermatitis, incontinence, and moisture as risk factors for pressure ulcer development. Res Nurs Health. 2014;37(3):204–18.CrossRefPubMed
46.
Taylor C. Importance of nutrition in preventing and treating pressure ulcers. Nurs Older People. 2017;29(6):33–9.CrossRefPubMed
47.
Amin AN, Cerceo EA, Deitelzweig SB, Pile JC, Rosenberg DJ, Sherman BM. Hospitalist perspective on the treatment of skin and soft tissue infections. Mayo Clin Proc. 2014;89(10):1436–51.CrossRefPubMed
48.
Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, et al. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect. 2016;22(Suppl 2):S27–36.CrossRefPubMed
49.
Metadata
Title
Incontinence-Associated Dermatitis: Pathogenesis, Contributing Factors, Prevention and Management Options
Authors
Hilde Beele
Steven Smet
Nele Van Damme
Dimitri Beeckman
Publication date
01-01-2018
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 1/2018
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-017-0507-1

Other articles of this Issue 1/2018

Drugs & Aging 1/2018 Go to the issue

Original Research Article

Drug Burden and its Association with Falls Among Older Adults in New Zealand: A National Population Cross-Sectional Study

Systematic Review

Brain Over Bladder: A Systematic Review of Dual Cholinesterase Inhibitor and Urinary Anticholinergic Use

Review Article

Treatment of Older Patients with Acute Lymphoblastic Leukaemia

Systematic Review

Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review

Original Research Article

The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People

Original Research Article

Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits